We welcome you to join fellow perfusionists to hear from Catherine Wentz, M.S., from the U.S. Food & Drug Administration. The regulatory process for approving medical devices and reporting adverse events for marketed medical devices remains a mystery to most non-regulators. The presentation will review this process and provide some clarity regarding what is behind the clearance/approval process and how the FDA relies on medical professionals to share post-market issues with these devices.
You may also like
Jeffrey P. Jacobs, MD, FACS, FACC, FCCP, to Present Abstract at AATS 2022
Jeffrey P. Jacobs, MD, FACS, FACC, FCCP, will present an abstract on the Variation in Survival Over Time in Patients with COVID-19 Supported with ECMO: A Multi-institutional analysis of 471 consecutive COVID-19 patients supported with ECMO…
by Nora Ioane
“From CardioVention to Comics”
We welcome you to join fellow perfusionists to hear from Hans Seiler, RN, ECCP, consultant on mini-bypass applications in hospitals in Canada, South Africa, the Middle East, India and Western Europe. The presentation will review the…
by Nora Ioane
“Update to STS/SCA/AmSECT/SABM Blood Management Guidelines for Cardiac Surgery”
We welcome you to join fellow perfusionists to hear from David Mazer, M.D, Professor in the Departments of Anesthesia and Physiology at the University of Toronto. The presentation will review evidence-based multidisciplinary and multimodal approaches to…
by Nora Ioane
Comments are closed.